comparemela.com

Latest Breaking News On - Trial alliance - Page 1 : comparemela.com

The Power of Patient Connection

Patient care begins with the patient, and Deb Schrag, MD, MPH, has spent her career keeping them the main focus of improving oncologic outcomes.

Chicago
Illinois
United-states
Boston
Massachusetts
Roslindale
Dana-farber-cancer-institute
Jamaica-plain
West-village
West-roxbury
Columbia-university
New-york

Craft work - PharmaTimes

Craft work - PharmaTimes
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Trial-alliance
Society-for-clinical-data-management
Avoca-quality-consortium
Decentralised-trial-alliance
Clinical-data-management

FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer

Lower rates of diarrhea and overall bowel dysfunction were reported with the use of neoadjuvant fluorouracil and oxaliplatin vs neoadjuvant pelvic chemoradiation with fluorouracil (5FCURT) in patients with locally advanced rectal cancer. However, lower rates of other toxicities were reported in patients treated with 5FCURT.

United-states
American
Trial-alliance
Patient-reported-outcomes
Common-terminology-criteria
Adverse-events
Clinical-oncology-annual-meeting

NextCell's publication of the phase I/II clinical trial in type I diabetes accepted

NextCell Pharma AB have had their article detailing the results of their phase I/II clinical trial in type I diabetes accepted in the peer-reviewed journal Diabetologia. NextCell Pharma AB is a. | March 28, 2023

Uppsala
Uppsala-lan
Sweden
Huddinge
Stockholm
Canada
Swedish
Patrik-fagerholm
Mathias-svahn
Ola-carlsson
Nextcell-pharma
Swedish-health

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.